medigraphic.com
SPANISH

Revista de Hematología

  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2016, Number 2

<< Back Next >>

Rev Hematol Mex 2016; 17 (2)

Fisher-Evans or Evans syndrome

Cimá-Castañeda MÁ, Ayala-López PM, Lara-Palacios MI, Abblitt-Luengas SM, Jiménez-Báez MV
Full text How to cite this article

Language: Spanish
References: 11
Page: 144-149
PDF size: 312.74 Kb.


Key words:

immune hemolytic anemia, immune thrombocytopenia, Fisher-Evans syndrome, Epstein-Barr virus.

ABSTRACT

Fisher-Evans syndrome is the manifestation of an immune hemolytic anemia that may be simultaneous or subsequent to an immune thrombocytopenia sometimes attached with immune neutropenia. It has been estimated that between 0.8 to 4% of patients with immune thrombocytopenia or immune hemolytic anemia presents this syndrome. Autoimmune diseases have been associated with virus infections. We report the case of a 58-year-old male with a suspected aplastic anemia diagnosed with an evolution of three weeks with a viral clinical manifestations. Epstein-Barr virus profile concluded with an acute mononucleosis. VGM hemolysis positive with indirect bilirubin of 2.1 g/dL, febrile reactions with secondary pan-agglutination to immune thrombocytopenic purple, direct Coombs positive, high HDL. Evans syndrome diagnosis was stablished. Bone marrow aspiration; discreetly decrease megakaryocytes present, morphologically show immature, polysegmentation of neutrophils and cell gigantism. Currently there are no reports of the prevalence of this syndrome in Mexico.


REFERENCES

  1. Cines DB, Liebman H, Stasi R. Pathobiology of secondary inmune thombocytopenia. Semin Hematol 2009;46:2-14.

  2. Jaime-Pérez JC, Guerra-Leal LN, López-Razo ON, Méndez- Ramírez N, Gómez-Almaguer D. Experiencie with Evans syndrome in academic referral center. Rev Bras Hematol Hemoter 2015;37:230-235.

  3. Norton A, Roberts I. Management of Evans Syndrome. Br J Haematol 2005;132:125-137.

  4. Aizpurua MF, Casali C, Cicco J, Mahuad C y col. Síndrome de Evans: desafío diagnóstico y terapéutico en una paciente crítica. Hematología 2015;19:60-65.

  5. Otaibi ZD, Rao R, Sadashiv SK. A case of Evans Syndrome: a clinical condition with under-recognized thrombotic risk. Br J Hematol 2015;4:205-209.

  6. Rosas M, Hernández M, Sardiñas J. Síndrome de Evans, Síndrome de anticuerpos antifosfolípidos primario, lupus eritematoso sistémico: la duda diagnóstica. Med Int Mex 2001;17:279-281.

  7. Balfour H, Dunmire S, Hogquist K. Infectious mononucleosis. Curr Top Microbiol Inmunol 2015;390:211-240.

  8. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med 2010;362:1993-2000.

  9. Michel M, Chanet V, Dechartres A, Morin A, et al. The spectrum of Evans syndrome in adults: new insight into the disease based on the analysis of 68 cases. Blood 2009;114:3167-3172.

  10. Garrido C. Avances en el conocimiento y manejo del síndrome linfoproliferativo autoinmune. An Pediat 2014;80:122e1–122e7.

  11. Cohen JI. Epstein-Barr virus infection. N Engl Med 2000;343:481-492.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Hematol Mex. 2016;17